Science Explorer Interactive view Map
Company · Palo Alto · United States

Eiger Biopharmaceuticals (United States)

eigerbio.comROR OpenAlex
Research works
25
▲ 49% vs 2013–17
Citations
608
24.4 per fractional work
Top-10% rate
13.3%
record average 16.5%
Open access
30%
world 28%

Not ranked overall: Eiger Biopharmaceuticals (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 0.63× its world share, 0 worksBiochemistry, Geneti…Computer Science: 2.59× its world share, 1 worksComputer ScienceEngineering: 1.34× its world share, 1 worksEngineeringHealth Professions: 1.02× its world share, 0 worksHealth ProfessionsMedicine: 1.76× its world share, 2 worksMedicineNursing: 2.75× its world share, 0 worksNursingDecision Sciences: 1.74× its world share, 0 worksDecision SciencesSocial Sciences: 1.33× its world share, 1 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Nursing, 2.8×. Every wedge is a field page.

Which keywords describe research at Eiger Biopharmaceuticals (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Antioxidants, DNA Damage, Risk Assessment, Immune Response, Sensitivity Analysis, Accident Prevention, Safety Culture and Oxidative Stress.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 9 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 9 words, with their numbers
  1. Antioxidants1▲ 13×5 topics
  2. DNA Damage1▲ 41×3 topics
  3. Epidemiology1▲ 1.33×9 topics
  4. Oxidative Stress1▲ 2.9×4 topics
  5. Immune Response1▲ 7.5×3 topics
  6. Risk Assessment1▲ 8.3×2 topics
  7. Sensitivity Analysis1▲ 36×2 topics
  8. Accident Prevention1▲ 65×2 topics
  9. Safety Culture1▲ 65×2 topics

Which research topics does Eiger Biopharmaceuticals (United States) publish most on?

By volume in 2022–2025: Lysosomal Storage Disorders Research, Open Source Software Innovations, Software Engineering Research and Structural Analysis of Composite Materials.

Lysosomal Storage Disord…1Lysosomal Storage Disorders Research: 1 fractional worksOpen Source Software Innovations: 0 fractional worksSoftware Engineering Research: 0 fractional worksStructural Analysis of Composite Materials: 0 fractional worksStructural Engineering and Vibration Analysis: 0 fractional worksStructural Analysis and …0Structural Analysis and Optimization: 0 fractional worksEducation and Communication Studies: 0 fractional worksProtease and Inhibitor Mechanisms: 0 fractional worksGlycogen Storage Diseases and Myoclonus: 0 fractional worksBone fractures and treatments: 0 fractional works
PhysiologyComputer Science ApplicationsInformation SystemsMechanical Engineering5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Lysosomal Storage Disorders Research Physiology 1 works
  2. 2 Open Source Software Innovations Computer Science Applications 0 works
  3. 3 Software Engineering Research Information Systems 0 works
  4. 4 Structural Analysis of Composite Materials Mechanical Engineering 0 works
  5. 5 Structural Engineering and Vibration Analysis Civil and Structural Engineering 0 works
  6. 6 Structural Analysis and Optimization Civil and Structural Engineering 0 works
  7. 7 Education and Communication Studies Education 0 works
  8. 8 Protease and Inhibitor Mechanisms Cancer Research 0 works
  9. 9 Glycogen Storage Diseases and Myoclonus Rheumatology 0 works
  10. 10 Bone fractures and treatments Epidemiology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available29.5%not open70.5%

World: 28% of research is openly available.

with international co-authors17.9%domestic only82.1%

World: 19% is written across borders.

How has Eiger Biopharmaceuticals (United States)'s research output changed?

Output in 2018–2022 was 49% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Palo Alto

All research institutions in Palo Alto

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.